Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Novabay Pharmaceuticals | NBY | 11. oct 2024 | 0.62 | -0.30 |
Novagold Resources | NG | 11. oct 2024 | 3.51 | +1.45 |
Novanta | NOVT | 11. oct 2024 | 175.02 | +2.51 |
Novartis ADR | NVS | 11. oct 2024 | 116.22 | +1.23 |
Novavax | NVAX | 11. oct 2024 | 12.53 | -2.91 |
Novo Integrated Sciences | NVOS | 11. oct 2024 | 0.26 | +5.88 |
Novo Nordisk ADR | NVO | 11. oct 2024 | 120.04 | +2.14 |
NovoCure | NVCR | 11. oct 2024 | 15.75 | +5.92 |
Novonix ADR | NVX | 11. oct 2024 | 2.30 | -4.17 |
NRG Energy | NRG | 11. oct 2024 | 89.75 | +2.45 |
NRx Pharmaceuticals | NRXP | 11. oct 2024 | 1.37 | -0.36 |
NSTS Bancorp | NSTS | 11. oct 2024 | 10.83 | +2.17 |
Nu Holdings | NU | 11. oct 2024 | 13.71 | +2.08 |
Nu Skin Enterprises | NUS | 11. oct 2024 | 6.27 | +0.16 |
Nuburu | BURU | 11. oct 2024 | 1.04 | +0.97 |
NuCana ADR | NCNA | 11. oct 2024 | 2.14 | -0.93 |
Nucor | NUE | 11. oct 2024 | 151.91 | +0.67 |
Nukkleus | NUKK | 11. oct 2024 | 0.27 | -0.83 |
Nurix Therapeutics | NRIX | 11. oct 2024 | 23.63 | +8.10 |
NuScale Power | SMR | 11. oct 2024 | 13.14 | +9.50 |
Nustar Energy C Pref | NS-C | 11. oct 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | 11. oct 2024 | 64.61 | 0.00 |
Nutex Health | NUTX | 11. oct 2024 | 19.79 | +4.60 |
Nutriband | NTRB | 11. oct 2024 | 7.91 | +11.41 |
Nutrien | NTR | 11. oct 2024 | 49.05 | +0.04 |
Nuvalent A | NUVL | 11. oct 2024 | 103.59 | +1.13 |
Nuvation Bio A | NUVB | 11. oct 2024 | 2.27 | +12.94 |
Nuvectis Pharma | NVCT | 11. oct 2024 | 6.40 | +3.39 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | 11. oct 2024 | 13.38 | +0.22 |
Nuveen Amtfree Municipal Value Fund | NUW | 11. oct 2024 | 14.29 | +0.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.